BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36291774)

  • 1. Latest Advances in the Management of Pediatric Gastrointestinal Stromal Tumors.
    Andrzejewska M; Czarny J; Derwich K
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
    Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
    JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Molecular Genetics of Gastrointestinal Stromal Tumors.
    Brčić I; Argyropoulos A; Liegl-Atzwanger B
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs].
    Kalfusová A; Kodet R
    Cesk Patol; 2017; 53(4):167-173. PubMed ID: 29227120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST.
    Astolfi A; Indio V; Nannini M; Saponara M; Schipani A; De Leo A; Altimari A; Vincenzi B; Comandini D; Grignani G; Secchiero P; Urbini M; Pantaleo MA
    Front Oncol; 2020; 10():504. PubMed ID: 32391261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics and targeted therapy of wild-type gastrointestinal stromal tumor].
    Tong X; Jiang Q; Zhang P; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):907-910. PubMed ID: 32927517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).
    Nannini M; Astolfi A; Urbini M; Indio V; Santini D; Heinrich MC; Corless CL; Ceccarelli C; Saponara M; Mandrioli A; Lolli C; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Cancer; 2014 Sep; 14():685. PubMed ID: 25239601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Wild-type gastroinestinal stromal tumors].
    Djerouni M; Dumont SN
    Bull Cancer; 2020 Apr; 107(4):499-505. PubMed ID: 32063345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
    Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
    Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ripretinib for the treatment of advanced gastrointestinal stromal tumor.
    Zalcberg JR
    Therap Adv Gastroenterol; 2021; 14():17562848211008177. PubMed ID: 33948116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Translational research and diagnosis in GIST].
    Wardelmann E
    Pathologe; 2012 Nov; 33 Suppl 2():273-7. PubMed ID: 22968735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy].
    Coindre JM; Emile JF; Monges G; Ranchère-Vince D; Scoazec JY
    Ann Pathol; 2005 Oct; 25(5):358-85; quiz 357. PubMed ID: 16498290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.
    Beadling C; Patterson J; Justusson E; Nelson D; Pantaleo MA; Hornick JL; Chacón M; Corless CL; Heinrich MC
    Cancer Med; 2013 Feb; 2(1):21-31. PubMed ID: 24133624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors.
    Shinomura Y; Kinoshita K; Tsutsui S; Hirota S
    J Gastroenterol; 2005 Aug; 40(8):775-80. PubMed ID: 16143881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients.
    Dudzisz-Śledź M; Klimczak A; Bylina E; Rutkowski P
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
    Gold JS; Dematteo RP
    Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).
    Nannini M; Urbini M; Astolfi A; Biasco G; Pantaleo MA
    J Transl Med; 2017 May; 15(1):113. PubMed ID: 28535771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of pediatric gastrointestinal stromal tumors.
    Agaram NP; Laquaglia MP; Ustun B; Guo T; Wong GC; Socci ND; Maki RG; DeMatteo RP; Besmer P; Antonescu CR
    Clin Cancer Res; 2008 May; 14(10):3204-15. PubMed ID: 18483389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
    Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
    BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.